Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2003
10/28/2003US6638736 Gene expression inhibition; cancer and neurodegenerative disease diagnosis; molecular hybridization
10/28/2003US6638735 Plasmid for gene expression in pichia ciferrii and transformation method using the same
10/28/2003US6638733 G-protein coupled receptors amplified in breast cancer
10/28/2003US6638731 Nucleotide sequences coding preferential polypeptide for use in diagnosis and treatment of alzheimer's disease
10/28/2003US6638722 Amplifying in mixture comprising DNA sample, first primer comprising random sequence of nucleotides at its 3' end and generic sequence 5' of random nucleotides, second primer comprising generic sequence only, heat stable DNA polymerase
10/28/2003US6638721 Human protein kinases and uses therefor
10/28/2003US6638720 Hybridization of probe as indication; transforming plants to impart resistance
10/28/2003US6638719 Genotyping biallelic markers
10/28/2003US6638717 Detecting an isolating duplicated nucleotide sequences; obtain random sample of nucleotide sequences, immobilize sample on microarrays, hybridize probes, detect hybridized probes, determine sequence of nucleotide segments
10/28/2003US6638714 Oligonucleotide primers for efficient detection of hepatitis C virus (HCV) and methods of use thereof
10/28/2003US6638552 Wheat flour from plant comprising recombinant expression cassette comrising a nucleic acid encoding polypeptide and seed-specific promoter
10/28/2003US6638524 Cosmetics, foods and beverages supplemented with purified strictinin
10/28/2003US6638516 Strain selection of pneumococcal surface proteins
10/28/2003US6638512 Method for treating subjects by using BAGE tumor rejection antigen precursors or tumor rejection antigens
10/28/2003US6638511 Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis
10/28/2003US6638510 Recombinant plasmid and a method of controlling the effects of Yersinia pestis
10/28/2003US6638505 For prevention of influenza virus binding to cells, therapy of schizophrenia and diagnosing chronic viral disease associated with development of cancer
10/28/2003US6638502 Comprising nucleic acid sequence encoding an amino terminal fragment of urokinase that comprises and epidermal growth factor-like domain; gene expression control; antimetastasis agents
10/28/2003US6638494 Iron hydroxide, ferric hydrate, iron oxide, iron mixed oxide or iron; di- or polycarboxylic acid stabilizer; aggregation prevention; antitumor and contrast agents; immune boosters, magnetic resonance imaging, cell fusion, gene transfer
10/28/2003US6638271 Multiple beam laser sculpting system and method
10/28/2003US6638264 Perfusion apparatus and methods for pharmaceutical delivery
10/28/2003CA2378579C Non-lactate-assimilating yeast for improving aerobic stability of silage
10/28/2003CA2319112C Use of ribozymes for functionating genes
10/28/2003CA2189427C Subtilisin 309 variants having decreased adsorption and increased hydrolysis
10/28/2003CA2153898C Method for generating single-stranded dna molecules
10/28/2003CA2118010C Antibodies specific for carcinoma-associated antigens
10/28/2003CA2095109C Process for production of exogenous gene or its product in plant cells
10/28/2003CA2074519C Allelic association of the dopamine (d2) receptor gene in compulsive disorders such as alcoholism
10/26/2003CA2425886A1 Root-specific conifer gene promoter and its use
10/23/2003WO2003087841A2 An ephrin-b receptor protein involved in carcinoma
10/23/2003WO2003087840A2 Protein involved in cancer
10/23/2003WO2003087836A1 Method of identifying transmembrane protein-interacting compounds
10/23/2003WO2003087832A2 Diagnosis of carcinoma using raigi polypeptides
10/23/2003WO2003087828A1 Enhanced gene expression system
10/23/2003WO2003087818A2 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction
10/23/2003WO2003087815A2 Method for the identification of inhibitors of the binding of are-containing mrn a and an hur protein
10/23/2003WO2003087812A1 Enclosed aquacultural systems for production of purified recombinant proteins
10/23/2003WO2003087774A2 Ecist microarrays for dual screening of dna hypermethylation and gene silencing
10/23/2003WO2003087771A2 Method for making a molecularly smooth surface
10/23/2003WO2003087765A2 System for tracing animal products
10/23/2003WO2003087412A2 Mutation detection and identification
10/23/2003WO2003087411A1 Method to inhibit cell growth using oligonucleotides
10/23/2003WO2003087410A1 Methods and devices for performing chemical reactions on a solid support
10/23/2003WO2003087408A2 Schizophrenia associated genes
10/23/2003WO2003087406A1 Diagnostic and therapeutic use of an atp-binding cassette gene and protein for neurodegenerative diseases
10/23/2003WO2003087404A1 Methods to predict patient responsiveness to tyrosine kinase inhibitors
10/23/2003WO2003087400A1 Methods and reagents for assaying protein kinase activity
10/23/2003WO2003087399A1 Nad)p)h oxidase inhibitors for increased glucose uptake and treatment of type ii diabetes
10/23/2003WO2003087397A2 Process control based on microbiological activity
10/23/2003WO2003087391A2 Hydrophobic zone device
10/23/2003WO2003087389A2 Biologic modulations with nanoparticles
10/23/2003WO2003087386A2 Methods for producing sulphurous fine chemicals by fermentation using meth-coding coryneform bacteria
10/23/2003WO2003087384A1 Preparation and use of dna-polyelectrolyte nanoparticles for gene transfer
10/23/2003WO2003087383A1 Compositions for delivering enyzmes involved in amino acid metabolism using recombinant ademo-associated virus virons (raav virons), and method and use for treating aminoi acid metabolic disorders using such raav virons
10/23/2003WO2003087382A1 Adeno-associated virus producer system
10/23/2003WO2003087381A1 Expression system of actinomycete-origin cytochrome p-450 in escherichia coli
10/23/2003WO2003087380A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003WO2003087379A1 Regulation of human protein kinase
10/23/2003WO2003087378A1 Nucleic acid immunization
10/23/2003WO2003087377A1 Insecticide proteins from photorabdus luminescens
10/23/2003WO2003087376A1 Caffeine synthase and use thereof
10/23/2003WO2003087375A1 Cartilage differentiation regulating gene
10/23/2003WO2003087374A1 Derivatives of the il-2 receptor gamma chain, their production and use.
10/23/2003WO2003087373A2 Production of recombinant fragments of muscle acetylcholine receptor and their use for ex vivo immunoadsorption of anti-ach receptor antibodies from myasthenic patients
10/23/2003WO2003087372A2 Growth factor derived from hepatome and the use of the same
10/23/2003WO2003087371A1 Antiviral therapy on the basis of rna interference
10/23/2003WO2003087370A1 Method and materials for producing deletion derivatives of polypeptides
10/23/2003WO2003087369A2 Ribozyme capable of specifically cleaving mmp-13
10/23/2003WO2003087368A2 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
10/23/2003WO2003087367A2 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/23/2003WO2003087365A1 Method of measuring human cyp3a inducibility
10/23/2003WO2003087358A1 Process for producing canthaxanthin
10/23/2003WO2003087357A2 Nucleic acid comprising retinal-specific regulatory region
10/23/2003WO2003087356A2 Helicokinin-receptor from insects
10/23/2003WO2003087354A2 Novel purified polypeptides involved in nucleotide transport and metabolism
10/23/2003WO2003087351A1 Hepatitis b viral variants with redused susceptibility to nucleoside analogs and uses thereof
10/23/2003WO2003087348A1 Packaging cell line for diphtheria toxin expressing non-replicating adenovirus
10/23/2003WO2003087346A1 Embryo modification and implantation
10/23/2003WO2003087345A2 Stimulation of nerve cell regeneration
10/23/2003WO2003087343A1 Production of stable collagens
10/23/2003WO2003087341A2 Targeted chromosomal mutagenesis using zinc finger nucleases
10/23/2003WO2003087338A2 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003WO2003087336A2 Estrogen receptor alpha regulated gene expression, related assays and therapeutics
10/23/2003WO2003087334A2 Use of aav integration efficiency element for mediating site-specific integration of a transcription unit
10/23/2003WO2003087331A2 Polyvalent cation-sensing receptor in atlantic salmon
10/23/2003WO2003087330A2 Vac-bac shuttle vector system
10/23/2003WO2003087329A2 Targeted cytocidal virionoids for antiangiogenesis
10/23/2003WO2003087324A2 Antibody gene transfer and recombinant aav
10/23/2003WO2003087323A2 Biologic modulations with nanoparticles
10/23/2003WO2003087321A2 Plant acyl-coa synthetases
10/23/2003WO2003087320A2 Antagonists of il-21 and modulation of il-21-mediated t cell responses
10/23/2003WO2003087318A2 Truncated 24 kda basic fibroblast growth factor
10/23/2003WO2003087317A2 Methods for targeting quadruplex dna
10/23/2003WO2003087313A2 Enhanced silk exsertion under stress
10/23/2003WO2003087312A2 Inhibition of tumor growth via peroxiredoxin 3
10/23/2003WO2003087308A2 Use of interleukin-24 to treat ovarian cancer
10/23/2003WO2003087306A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
10/23/2003WO2003087301A2 Methods and compositions for dna manipulation
10/23/2003WO2003087294A2 Recombining viral vectors for the tetracycline-regulated expression of genes
10/23/2003WO2003087163A1 METHOD OF CONSTRUCTING scDb LIBRARY